Quanterix (NASDAQ: QTRX)
Quanterix Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Quanterix Company Info
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
News & Analysis
Why Quanterix Stock Bounced Back on Wednesday
The market might, just might, have over-reacted to the company's dispiriting second-quarter results the previous day.
Why Quanterix Shares Plunged by Nearly 55% Today
Investors gave the thumbs-down to the biotech's latest reported quarter.
Valuation
Earnings Transcripts
Quanterix Corporation (QTRX) Q3 2021 Earnings Call Transcript
QTRX earnings call for the period ending September 30, 2021.
Quanterix Corporation (QTRX) Q1 2020 Earnings Call Transcript
QTRX earnings call for the period ending March 31, 2020.
Quanterix Corporation (QTRX) Q4 2019 Earnings Call Transcript
QTRX earnings call for the period ending December 31, 2019.
Quanterix Corporation (QTRX) Q3 2019 Earnings Call Transcript
QTRX earnings call for the period ending September 30, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.